0001517941-19-000002.txt : 20191016 0001517941-19-000002.hdr.sgml : 20191016 20191016133917 ACCESSION NUMBER: 0001517941-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191016 DATE AS OF CHANGE: 20191016 EFFECTIVENESS DATE: 20191016 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmell Therapeutics Corp CENTRAL INDEX KEY: 0001517941 IRS NUMBER: 263671988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-351149 FILM NUMBER: 191152517 BUSINESS ADDRESS: STREET 1: 10 SOUTH TOWER STREET 2: 320 E. NORTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15212 BUSINESS PHONE: (412) 508-6519 MAIL ADDRESS: STREET 1: 10 SOUTH TOWER STREET 2: 320 E. NORTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15212 D 1 primary_doc.xml X0708 D LIVE 0001517941 Carmell Therapeutics Corp 2403 Sidney Street, Suite 300 PITTSBURGH PA PENNSYLVANIA 15203 215-688-6196 DELAWARE CarMell, LLC None Corporation true Randolph Hubbell c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Director James Hart c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Donna Godward c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Richard Upton c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director James F. Jordan c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director David W. Anderson c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director Stephanie Kladakis c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Wendy DiCicco c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director Biotechnology Decline to Disclose 06b false 2019-09-25 false true true false 0 Alere Financial Partners 109761 None None 6851 Jericho Turnpike #130 Syosset NY NEW YORK 11791 All States false 2300000 80000 2220000 Offering consists of $2,000,000 of Convertible Notes and $300,000 of Warrants false 2 184000 true 0 Represents up to 8% placement agent fee. 0 false Carmell Therapeutics Corp /s/ Randolph W. Hubbell Randolph W. Hubbell Chief Executive Officer and President 2019-10-15